Cargando…

Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis

Currently the longitudinal proteomic profile of post-ischemic stroke recovery is relatively unknown with few well-accepted biomarkers or understanding of the biological systems that underpin recovery. We aimed to characterize plasma derived biological pathways associated with recovery during the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Vinh A., Riddell, Nina, Crewther, Sheila G., Faou, Pierre, Rajapaksha, Harinda, Howells, David W., Hankey, Graeme J., Wijeratne, Tissa, Ma, Henry, Davis, Stephen, Donnan, Geoffrey A., Carey, Leeanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399641/
https://www.ncbi.nlm.nih.gov/pubmed/32849183
http://dx.doi.org/10.3389/fneur.2020.00692
_version_ 1783566181359157248
author Nguyen, Vinh A.
Riddell, Nina
Crewther, Sheila G.
Faou, Pierre
Rajapaksha, Harinda
Howells, David W.
Hankey, Graeme J.
Wijeratne, Tissa
Ma, Henry
Davis, Stephen
Donnan, Geoffrey A.
Carey, Leeanne M.
author_facet Nguyen, Vinh A.
Riddell, Nina
Crewther, Sheila G.
Faou, Pierre
Rajapaksha, Harinda
Howells, David W.
Hankey, Graeme J.
Wijeratne, Tissa
Ma, Henry
Davis, Stephen
Donnan, Geoffrey A.
Carey, Leeanne M.
author_sort Nguyen, Vinh A.
collection PubMed
description Currently the longitudinal proteomic profile of post-ischemic stroke recovery is relatively unknown with few well-accepted biomarkers or understanding of the biological systems that underpin recovery. We aimed to characterize plasma derived biological pathways associated with recovery during the first year post event using a discovery proteomics workflow coupled with a topological pathway systems biology approach. Blood samples (n = 180, ethylenediaminetetraacetic acid plasma) were collected from a subgroup of 60 first episode stroke survivors from the Australian START study at 3 timepoints: 3–7 days (T1), 3-months (T2) and 12-months (T3) post-stroke. Samples were analyzed by liquid chromatography mass spectrometry using label-free quantification (data available at ProteomeXchange with identifier PXD015006). Differential expression analysis revealed that 29 proteins between T1 and T2, and 33 proteins between T1 and T3 were significantly different, with 18 proteins commonly differentially expressed across the two time periods. Pathway analysis was conducted using Gene Graph Enrichment Analysis on both the Kyoto Encyclopedia of Genes and Genomes and Reactome databases. Pathway analysis revealed that the significantly differentiated proteins between T1 and T2 were consistently found to belong to the complement pathway. Further correlational analyses utilized to examine the changes in regulatory effects of proteins over time identified significant inhibitory regulation of clusterin on complement component 9. Longitudinal post-stroke blood proteomics profiles suggest that the alternative pathway of complement activation remains in a state of higher activation from 3-7 days to 3 months post-stroke, while simultaneously being regulated by clusterin and vitronectin. These findings also suggest that post-stroke induced sterile inflammation and immunosuppression could inhibit recovery within the 3-month window post-stroke.
format Online
Article
Text
id pubmed-7399641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73996412020-08-25 Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis Nguyen, Vinh A. Riddell, Nina Crewther, Sheila G. Faou, Pierre Rajapaksha, Harinda Howells, David W. Hankey, Graeme J. Wijeratne, Tissa Ma, Henry Davis, Stephen Donnan, Geoffrey A. Carey, Leeanne M. Front Neurol Neurology Currently the longitudinal proteomic profile of post-ischemic stroke recovery is relatively unknown with few well-accepted biomarkers or understanding of the biological systems that underpin recovery. We aimed to characterize plasma derived biological pathways associated with recovery during the first year post event using a discovery proteomics workflow coupled with a topological pathway systems biology approach. Blood samples (n = 180, ethylenediaminetetraacetic acid plasma) were collected from a subgroup of 60 first episode stroke survivors from the Australian START study at 3 timepoints: 3–7 days (T1), 3-months (T2) and 12-months (T3) post-stroke. Samples were analyzed by liquid chromatography mass spectrometry using label-free quantification (data available at ProteomeXchange with identifier PXD015006). Differential expression analysis revealed that 29 proteins between T1 and T2, and 33 proteins between T1 and T3 were significantly different, with 18 proteins commonly differentially expressed across the two time periods. Pathway analysis was conducted using Gene Graph Enrichment Analysis on both the Kyoto Encyclopedia of Genes and Genomes and Reactome databases. Pathway analysis revealed that the significantly differentiated proteins between T1 and T2 were consistently found to belong to the complement pathway. Further correlational analyses utilized to examine the changes in regulatory effects of proteins over time identified significant inhibitory regulation of clusterin on complement component 9. Longitudinal post-stroke blood proteomics profiles suggest that the alternative pathway of complement activation remains in a state of higher activation from 3-7 days to 3 months post-stroke, while simultaneously being regulated by clusterin and vitronectin. These findings also suggest that post-stroke induced sterile inflammation and immunosuppression could inhibit recovery within the 3-month window post-stroke. Frontiers Media S.A. 2020-07-28 /pmc/articles/PMC7399641/ /pubmed/32849183 http://dx.doi.org/10.3389/fneur.2020.00692 Text en Copyright © 2020 Nguyen, Riddell, Crewther, Faou, Rajapaksha, Howells, Hankey, Wijeratne, Ma, Davis, Donnan and Carey. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Nguyen, Vinh A.
Riddell, Nina
Crewther, Sheila G.
Faou, Pierre
Rajapaksha, Harinda
Howells, David W.
Hankey, Graeme J.
Wijeratne, Tissa
Ma, Henry
Davis, Stephen
Donnan, Geoffrey A.
Carey, Leeanne M.
Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
title Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
title_full Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
title_fullStr Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
title_full_unstemmed Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
title_short Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
title_sort longitudinal stroke recovery associated with dysregulation of complement system—a proteomics pathway analysis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399641/
https://www.ncbi.nlm.nih.gov/pubmed/32849183
http://dx.doi.org/10.3389/fneur.2020.00692
work_keys_str_mv AT nguyenvinha longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT riddellnina longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT crewthersheilag longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT faoupierre longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT rajapakshaharinda longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT howellsdavidw longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT hankeygraemej longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT wijeratnetissa longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT mahenry longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT davisstephen longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT donnangeoffreya longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis
AT careyleeannem longitudinalstrokerecoveryassociatedwithdysregulationofcomplementsystemaproteomicspathwayanalysis